Richard L. Hudson

Despite the Nobel-induced champagne now flowing in Berlin, Jülich, Paris and Cardiff, the fact remains that Europe has a fundamental problem in the quality of its science.

Stockholm’s biomedical university is looking to double its seed capital to get discoveries to market, according to President Harriet Wallberg-Henriksson.

Managing clinical trials is, for the pharmaceutical industry, a growing headache in Europe. One key to the problem: the teaching hospital.

The EIT finally squeaks through the Brussels bureaucracy – but more dead than alive

Science|Business editor Richard L. Hudson has a few numbers that, if you care about Europe’s future in technology markets, might make you choke on your coffee.

Big changes are in store for one of Britain’s most prestigious universities if, as expected, University College London signs off on a modernising green paper from Provost Malcolm Grant.

An R&D conference highlights the mutual incomprehension dividing industry and academics in Europe – and some suggestions for bridging the gap.

Portugal takes the EU helm on 1 July - and is planning new measures to revitalize the "Lisbon Agenda" for high-tech growth, says tech-policy leader Carlos Zorrinho.

Angelika Niebler, chair of the European Parliament committee that created the popular new European Research Council, vows to protect its political independence.

Pollsters find most academics now back reforms to collaborate with business, increase private funding and streamline curricula.